Login / Signup

Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin America.

Ricardo AlonsoAnibal S ChertcoffFelisa Del V LeguizamónLorna Galleguillos GoiryMaria Barbara EizaguirreRoberto RodríguezMarta SosaSusana CarballidoVerónica CruchetAgnes de Jong-MartisSusana GiachelloPaula HenestrozaFlavia FerrandinaJohana BauerAdriana CarráBerenice Anabel Silva
Published in: Multiple sclerosis journal - experimental, translational and clinical (2021)
COVID-19 vaccines applied in LATAM proved safe for MS patients.
Keyphrases
  • coronavirus disease
  • sars cov
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • mass spectrometry
  • multiple sclerosis
  • peritoneal dialysis